LPCAT3 and colonic neoplasm: It lowered pro-inflammatory cytokine levels of IL-1β and TNF-α and enhanced carnitine palmitoyl transferase 1A (CPT1A) and lysophosphatidylcholine acyltransferase 3 (LPCAT3), thereby attenuating the anti-proliferative effect of SIN (2.5 mM) on human colon cancer cells (HT-29, HCT-116, and SW-480) [41].